Podcast Episodes
Back to SearchWorld MS Day Special: Immunic reveals new hope for progressive MS
Episode 199
Today we welcome Dr. Daniel Vitt, CEO of Immunic Therapeutics.
With World MS Day being tomorrow, the 30th of May, this is the perfect moment to focus…
4 months, 2 weeks ago
The problem at the heart of drug discovery: Lexogen & Ochre Bio on the power of AI on human data
Episode 198
Today I am welcoming two guests: Quin Wills, CEO of Ochre Bio, a biotech developing RNA therapies for chronic liver disease using AI models, and Stép…
4 months, 3 weeks ago
Freeze variability, not progress: strengthen your cell therapy supply chain from the start
Episode 197
Today, we're digging into a topic that's getting a lot more attention lately, how early decisions in cell therapy end up shaping or complicating ever…
5 months ago
Making labs smarter for scientific breakthroughs
Episode 196
Today, we dive into the future of lab management with Ryan Cawood, CEO and co-founder of Lab Thread. Ryan's journey spans groundbreaking work in viro…
5 months, 1 week ago
How Epicrispr is leveraging CRISPR without cutting DNA
Episode 195
This week we dive into the Beyond Biotech archive to bring you a discussion with Dr Stanley Qi, the founder of Epicrispr.
Epicrispr is an epigenetic e…
5 months, 2 weeks ago
Diagonal Therapeutics’ innovative clustering antibodies for vascular diseases
Episode 194
Today we’re joined by Patrick Andre, Chief Scientific Officer at Diagonal Therapeutics.
A trained vascular biologist, Patrick’s career spans groundbre…
5 months, 3 weeks ago
Argobio: the venture model building Europe’s next biotech champions
Episode 193
Our guest today is Thierry Laugel, Managing Partner of Kurma & Chairman of Argobio. With a PharmD, PhD in pharmacology, and an INSEAD MBA, Thierry ha…
5 months, 4 weeks ago
Multi-agent AI delivers reliable and scalable insights for single-cell omics
Episode 192
Today, we're exploring the transformative potential of AI in biopharma—separating hype from reality, and zooming in on the complexities of single-cel…
6 months ago
Nionyx Bio's kidney gene therapy wins the 2026 BIO-Europe Spring Startup Spotlight
Episode 191
This week we welcome Magdalena Tyrpien, CEO, Co-Founder and President of Nionyx Bio, just days after the company took first place in the BIO-Europe S…
6 months, 2 weeks ago
HaemaLogiX - precision immunotherapy for multiple myeloma
Episode 190
Today, we welcome Dr Rosanne Dunn, Chief Scientific Officer and co-founder of HaemaLogiX, an Australian clinical-stage biotech company that's develop…
6 months, 2 weeks ago